Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability.

Stephen D Robinson1, Louise E Reynolds, Lorenza Wyder

  • 1Cell Adhesion and Disease/Tumour Biology Laboratory, Cancer Research UK Clinical Centre, Queen Mary's School of Medicine & Dentistry at Barts & The London, John Vane Science Centre, London, United Kingdom. s.d.robinson@cancer.org.uk

Arteriosclerosis, Thrombosis, and Vascular Biology
|September 4, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing lung cancer therapy - leveraging cell biology to improve immunotherapy and anti-angiogenic strategies.

Journal of cell science·2026
Same author

WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins.

Cancer immunology research·2026
Same author

Angiocrine and pericrine signaling: how endothelial cells and pericytes drive cancer progression and therapy resistance.

Physiological reviews·2025
Same author

Angiocrine and Pericrine Signaling: How Endothelial Cells and Pericytes Drive Cancer Progression and Therapy Resistance.

Physiological reviews·2025
Same author

Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy.

Cancer immunology, immunotherapy : CII·2025
Same author

Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulin.

Microbiome research reports·2025

Beta3-integrin deficiency enhances vascular endothelial growth factor-A (VEGF-A)-induced blood vessel permeability by increasing Flk-1 expression on endothelial cells. This heightened sensitivity to VEGF-A leads to increased vascular leakage in beta3-null mice.

Area of Science:

  • Integrin signaling in vascular biology
  • Endothelial cell function and angiogenesis
  • Molecular mechanisms of vascular permeability

Background:

  • Beta3-integrin plays a role in angiogenesis and endothelial cell behavior.
  • Vascular endothelial growth factor (VEGF) is a key regulator of blood vessel formation and permeability.
  • Flk-1 (VEGFR-2) is a critical receptor for VEGF signaling in endothelial cells.

Purpose of the Study:

  • To investigate the role of beta3-integrin in mediating VEGF-A-induced blood vessel permeability.
  • To determine if beta3-integrin deficiency affects VEGF-A-induced permeability through Flk-1 signaling.

Main Methods:

  • Utilized the Miles assay to measure VEGF-A-induced plasma leakage in beta3-null and wild-type mice.
  • Assessed blood vessel structure via light and electron microscopy.

Related Experiment Videos

  • Analyzed endothelial cell-cell adhesion proteins using Western blot, flow cytometry, and immunofluorescence.
  • Investigated the effect of Flk-1 inhibition on VEGF-A-induced leakage in beta3-null mice.

    • Main Results:

    • VEGF-A-induced plasma leakage was significantly enhanced in beta3-null mice compared to wild-type controls.
    • No significant differences were observed in blood vessel structure or endothelial cell-cell adhesion proteins.
    • VEGF-A-induced leakage was abolished in beta3-null mice upon Flk-1 inhibition, confirming its role.

    Conclusions:

    • Beta3-integrin deficiency increases endothelial cell sensitivity to VEGF-A.
    • This heightened sensitivity is attributed to elevated Flk-1 expression on endothelial cells.
    • Consequently, beta3-integrin deficiency enhances VEGF-A-mediated vascular permeability.